Literature DB >> 9716980

Infectious causes of chronic inflammatory diseases and cancer.

G H Cassell1.   

Abstract

Powerful diagnostic technology, plus the realization that organisms of otherwise unimpressive virulence can produce slowly progressive chronic disease with a wide spectrum of clinical manifestations and disease outcomes, has resulted in the discovery of new infectious agents and new concepts of infectious diseases. The demonstration that final outcome of infection is as much determined by the genetic background of the patient as by the genetic makeup of the infecting agent is indicating that a number of chronic diseases of unknown etiology are caused by one or more infectious agents. One well-known example is the discovery that stomach ulcers are due to Helicobacter pylori. Mycoplasmas may cause chronic lung disease in newborns and chronic asthma in adults, and Chlamydia pneumoniae, a recently identified common cause of acute respiratory infection, has been associated with atherosclerosis. A number of infectious agents that cause or contribute to neoplastic diseases in humans have been documented in the past 6 years. The association and causal role of infectious agents in chronic inflammatory diseases and cancer have major implications for public health, treatment, and prevention.

Entities:  

Mesh:

Year:  1998        PMID: 9716980      PMCID: PMC2640277          DOI: 10.3201/eid0403.980339

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  88 in total

1.  Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility.

Authors:  P T Rudd; G H Cassell; K B Waites; J K Davis; L B Duffy
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

Review 3.  Mycoplasmas as agents of human disease.

Authors:  G H Cassell; B C Cole
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

Review 4.  Respiratory infections in the newborn.

Authors:  P H Dennehy
Journal:  Clin Perinatol       Date:  1987-09       Impact factor: 3.430

5.  Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis.

Authors:  R F Parker; J K Davis; G H Cassell; H White; D Dziedzic; D K Blalock; R B Thorp; J W Simecka
Journal:  Am Rev Respir Dis       Date:  1989-08

6.  Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.

Authors:  K Laitinen; A Laurila; L Pyhälä; M Leinonen; P Saikku
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 7.  Virus-induced airway hyperresponsiveness in man.

Authors:  P J Sterk
Journal:  Eur Respir J       Date:  1993-06       Impact factor: 16.671

8.  The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice.

Authors:  F W Henderson; W A Clyde; A M Collier; F W Denny; R J Senior; C I Sheaffer; W G Conley; R M Christian
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

9.  Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection.

Authors:  G B Valencia; F Banzon; M Cummings; W M McCormack; L Glass; M R Hammerschlag
Journal:  Pediatr Infect Dis J       Date:  1993-07       Impact factor: 2.129

10.  INFECTIOUS CATARRH OF THE ALBINO RAT : I. EXPERIMENTAL TRANSMISSION IN RELATION TO THE ROLE OF ACTINOBACILLUS MURIS.

Authors:  J B Nelson
Journal:  J Exp Med       Date:  1940-11-30       Impact factor: 14.307

View more
  18 in total

1.  Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts.

Authors:  James P Fabisiak; Fei Gao; Robyn G Thomson; Robert M Strieter; Simon C Watkins; James H Dauber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06-02       Impact factor: 5.464

2.  Persons and pathogens: consequences of co-existence.

Authors:  M C Powanda
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

Review 3.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

4.  Mycoplasma pneumoniae respiratory tract infections among Greek children.

Authors:  M Almasri; E Diza; A Papa; M Eboriadou; E Souliou
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

5.  Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis.

Authors:  J M Hickman-Davis; J R Lindsey; S Matalon
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 6.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.

Authors:  Thomas J Hannan; Indira U Mysorekar; Chia S Hung; Megan L Isaacson-Schmid; Scott J Hultgren
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

8.  Microbial stimulation by Mycoplasma fermentans synergistically amplifies IL-6 release by human lung fibroblasts in response to residual oil fly ash (ROFA) and nickel.

Authors:  Fei Gao; Aaron Barchowsky; Antonia A Nemec; James P Fabisiak
Journal:  Toxicol Sci       Date:  2004-06-30       Impact factor: 4.849

9.  Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma.

Authors:  Rinaldo Pellicano; Vincenzo Mazzaferro; Walter Franco Grigioni; Miguel Angel Cutufia; Sharmila Fagoonee; Lorenzo Silengo; Mario Rizzetto; Antonio Ponzetto
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

10.  Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method.

Authors:  N Cíftçíoglu; M A Miller-Hjelle; J T Hjelle; E O Kajander
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.